Business Wire

RefleXion Highlights New Cancer Treatment Research Abstracts for Presentation at ASTRO 2022

HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion ® Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality for treating all stages of cancer, today ...
Business Wire

Naveris Collaborators Present Award-winning Abstract at ASTRO 2022 on Potential of NavDx to Inform Treatment Strategies in HPV-driven Cancers

NATICK, Mass.--(BUSINESS WIRE)--Naveris, Inc., a leader in molecular diagnostics for viral cancers, today announced that the company and the principle investigator at Mayo Clinic will present its ...
KTLA

Together with Siemens Healthineers, Varian Showcases Technologies and Services Spanning the Full Cancer Care Continuum at ASTRO 2022

PALO ALTO, Calif., Oct. 20, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end imaging and cancer care technologies and services ...
FOX8 Cleveland

PreludeDx™ to Present DCISionRTÒ and Novel Residual Risk Subtype Prospective Data During Scientific Oral Session at ASTRO 2022 Annual Meeting

LAGUNA HILLS, Calif., Oct. 21, 2022 /PRNewswire/ -- Prelude Corporation (PreludeDxä), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today that its ...
Medscape

Move to Shorter Hypofractionated RT for High-Risk Prostate Cancer

SAN ANTONIO — Patients with high-risk prostate cancer can be safety treated with a shorter hypofractionated radiotherapy regimen without compromising overall and disease-free survival outcomes, ...
Nasdaq

Alpha Tau Announces Multiple Corporate Updates Ahead of 2022 Annual Meeting of the American Society for Radiation Oncology

- Medicines and Healthcare products Regulatory Agency of the United Kingdom approves clinical trial in squamous cell carcinoma of the vulva at Addenbrookes Hospital in Cambridge- - Health Canada ...